Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention

Cancer Letters ◽

10.1016/s0304-3835(98)00254-7 ◽

1998 ◽

Vol 134 (2) ◽

pp. 201-207 ◽

Author(s):

Guenther Winde ◽

Norbert Lügering ◽

Bernhard Glodny ◽

Kurt W. Schmid ◽

Oliver Müller ◽

...

Keyword(s):

Tyrosine Kinase ◽

Low Dose ◽

Rectal Mucosa ◽

Her 2 ◽

Kinase Expression

Download Full-text

Review for "Contribution of the SYK Tyrosine kinase expression to human iNKT self‐reactivity"

10.1002/eji.201948416/v2/review2 ◽

2020 ◽

Keyword(s):

Tyrosine Kinase ◽

Kinase Expression

Download Full-text

Review for "Contribution of the SYK Tyrosine kinase expression to human iNKT self‐reactivity"

10.1002/eji.201948416/v2/review1 ◽

2020 ◽

Keyword(s):

Tyrosine Kinase ◽

Kinase Expression

Download Full-text

Decision letter for "Contribution of the SYK Tyrosine kinase expression to human iNKT self‐reactivity"

10.1002/eji.201948416/v2/decision1 ◽

2020 ◽

Keyword(s):

Tyrosine Kinase ◽

Kinase Expression

Download Full-text

Review for "Contribution of the SYK Tyrosine kinase expression to human iNKT self‐reactivity"

10.1002/eji.201948416/v1/review2 ◽

2019 ◽

Keyword(s):

Tyrosine Kinase ◽

Kinase Expression

Download Full-text

The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: a systematic review and meta analysis

10.1016/s0960-9776(21)00145-4 ◽

2021 ◽

Vol 56 ◽

pp. S41

Author(s):

Y. Yu ◽

J. Zhang ◽

K. Huang ◽

Y. Lin ◽

C. Song

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Efficacy And Safety ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors

Leukemia & Lymphoma ◽

10.1080/10428194.2017.1357178 ◽

2017 ◽

Vol 59 (3) ◽

pp. 766-769 ◽

Author(s):

Emilie Cayssials ◽

Florence Tartarin ◽

Joëlle Guilhot ◽

Nathalie Sorel ◽

Jean Claude Chomel ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Myeloid Leukemia ◽

Low Dose ◽

Kinase Inhibitors ◽

Molecular Response

Download Full-text

Synthesis and biological evaluation of pyrrolopyridazine derivatives as novel HER-2 tyrosine kinase inhibitors

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/j.bmcl.2009.09.038 ◽

2009 ◽

Vol 19 (22) ◽

pp. 6437-6440 ◽

Author(s):

Peng Cho Tang ◽

Jun Feng ◽

Li Huang ◽

Zhe Xu ◽

Ling Cheng ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Biological Evaluation ◽

Her 2 ◽

Synthesis And Biological Evaluation

Download Full-text

Cytoplasmic c-ros oncogene 1 receptor tyrosine kinase expression may be associated with the development of human oral squamous cell carcinoma

Oncology Letters ◽

10.3892/ol.2015.3340 ◽

2015 ◽

Vol 10 (2) ◽

pp. 934-940 ◽

Author(s):

YONG CHENG ◽

YANG SUN ◽

LI-ZHEN WANG ◽

YOU-CHENG YU ◽

XIAOJUN DING

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Squamous Cell ◽

Receptor Tyrosine Kinase ◽

Kinase Expression

Download Full-text

Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro

Chemical Papers ◽

10.1007/s11696-019-00686-0 ◽

2019 ◽

Vol 73 (6) ◽

pp. 1333-1345

Author(s):

Shuyu Jin ◽

Xiuyun Sun ◽

Dan Liu ◽

Hua Xie ◽

Yu Rao

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Biological Study ◽

Design Synthesis ◽

Her 2 ◽

Low Cytotoxicity

Download Full-text

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80420-9 ◽

2006 ◽

Vol 4 (2) ◽

pp. 165

Author(s):

M. Zilli ◽

De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

P. Marchetti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text